Search

everythinglearnresearchcommunity

for

Search:↓

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Systemic diseases can cause hair loss, which is often reversible with treatment.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Mice with autoimmune hair loss showed signs of heart problems.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Finasteride caused enlarged breast tissue in a 62-year-old man.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Akt2 protein is essential for normal cell division in early mouse embryos.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.